?

Blanchard Cheryl R

President, CEO, Director
Anika Therapeutics, Inc.
US, Bedford [HQ]
CIK 1326530

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
113,791
Price per Share :
$16.19
Equivalence :
$1,842,276.29

Transaction History

  • 113,791 Shares After Transaction
    Value : $n/a
    $0.0
    03/10/23
  • Footnotes:
    #1 Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022.
    #2 Reflects an aggregate of 13,211 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023.
    #3 Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations.
  • 100,580 Shares After Transaction
    Value : $2,625,138.00
    $344,807.10
    03/10/23
  • 129,614 Shares After Transaction
    Value : $n/a
    $0.0
    03/11/24
  • 122,641 Shares After Transaction
    Value : $3,117,534.22
    $177,253.66
    03/11/24
  • 142,642 Shares After Transaction
    Value : $n/a
    $0.0
    03/11/24

Get PRO Today.

PRO unlocks 7 more insider transactions made by Blanchard Cheryl R